A randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast cancer (GeparSixto).
Gunter Von Minckwitz
Honoraria - Roche; Sanofi
Andreas Schneeweiss
No relevant relationships to disclose
Christoph Salat
No relevant relationships to disclose
Mahdi Rezai
No relevant relationships to disclose
Dirk Michael Zahm
No relevant relationships to disclose
Peter Klare
No relevant relationships to disclose
Jens U. Blohmer
No relevant relationships to disclose
Hans Tesch
No relevant relationships to disclose
Fariba Khandan
No relevant relationships to disclose
Sebastian Jud
No relevant relationships to disclose
Christian Jackisch
Honoraria - Roche; Sanofi
Keyur Mehta
No relevant relationships to disclose
Sibylle Loibl
No relevant relationships to disclose
Michael Untch
No relevant relationships to disclose